Ge Zheng-Yan, Jin Long, Yang Bin, Dong Xiao-Xia, Li Hong-Kun, Guo Yu-Jie, Ren Ye, Hong Xiao-Hua, Wang Yang-Hui, Liu Jian-Xun
Zhongguo Zhong Xi Yi Jie He Za Zhi. 2017 Mar;37(3):331-337.
Objective To observe effects of Jiangtang Xiaozhi Tablet (JTXZT) on homeostasis model of assessment for insulin resistance index (HOMA-IR) , insulin sensitivity index ( ISI) , expres- sions of insulin (INS) and insulin receptor (InsR) in pancreas tissues of KK-A(y) transgenic mice model of diabetes mellitus (DM). Methods KK-A(y) transgenic mice were fed with high fat forage to induce hyper- glycemic obese DM model. The C,7ice at same age were used as a normal control group (fed with e- qual volume of sterile water, n =11). Successful modeled 55 mice with DM obesity were divided into 5 groups by random digit table (11 in each group) , including the model group (fed with equal volume of ster- ile water, with no treatment) , the Pioglitazone Hydrochloride Tablet treatment group (8 mg/kg; as a posi- tive control group) , and JTXZT groups [high (10. 0 g crude drugs/kg) , middle (5. 0 g crude drugs/kg) and low dose (2. 5 g crude drugs/kg) ]. All medications were fed by gastrogavage, once per day for 8 succes- sive weeks. All mice were weighed and levels of random blood glucose (RBG) determined after 8 weeks of treatment. Blood was collected from ophthalmic vein. Levels of insulin (INS) , serum total cholesterol (TC) and triglyceride (TG) were detected. HOMA-IR and ISI were calculated. The morphological changes of pancreas tissues were extracted for performed pathological examinations. The expressions of INS and insulin receptor (InsR ) were measured by immunohistochemistry ( IHC ). Expressions of insulin receptorp βInsRP) and insulin receptor substrate-1 (IRS-1) in pancreas tissues were detected using Western blot. Results Compared with the normal control group, obesity, obviously increased blood glu- cose and blood lipids occurred in each group after modeling (P <0. 01). After 8 weeks of medication mice in the model group had put up body weight (P <0. 01) , blood glucose and blood lipids were kept on quite higher levels. Compared with the model group, body weight, serum levels of TG, INS, and HOMA-IR obvi- ously decreased in each JTXZT group (P <0. 05, P <0. 01). Besides, RBG decreased obviously lower in the high dose JTXZT group (P <0. 01). ISI obviously increased in low and high dose JTXZT groups (P < 0. 05, P <0. 01). Pathological results of HE staining in pancreas showed that atrophied islets with obvious- ly reduced numbers in the model group. They were sparsely distributed with reduced islet density.-Islet cells were compensatively hypertrophy, with degenerated vacuoles. Apoptosis of islet cells could also be seen in the model group, manifested as swollen cytoplasm and paryopyknosis. Islet number was obvious- ly increased in high and middle dose JTXZT groups, with reduced apoptosis and degenerated cells. Re- sults of IHC assay showed, as compared with the normal control group, the grey values of INS and InsR were significantly decreased in the model group (P <0. 01). Compared with the model group, IOD values of INS and InsR (IOD) were significantly increased in each JTXZT group (P <0. 05, P <0. 01). Results from Western blot showed that protein expressions of InsRP βnd IRS-1 were obviously decreased in the model group, as compared with the normal control group (P <0. 01). Compared with the model group, protein expressions of InsRP βnd IRS-1 were obviously increased in each JTXZT group (P <0. 01) , but with no statistical difference as compared with the Pioglitazone Hydrochloride Tablet treatment group (P > 0. 05). Conclusions JTXZT had obvious roles in decreasing levels of blood glucose, serum lipids, and improving insulin resistance in KK-Ayt(r) ansgenic mice model with diabetic obesity. Its mechanism might involve in increasing expressions of lnsRp and IRS-1 in pancreas cells, promoting the integration of INS to its receptors, and thereby improving glucose metabolism , lipid metabolism , and IR state.
目的 观察降糖消脂片(JTXZT)对糖尿病(DM)KK-A(y)转基因小鼠模型胰腺组织中胰岛素抵抗指数(HOMA-IR)、胰岛素敏感性指数(ISI)、胰岛素(INS)及胰岛素受体(InsR)表达的影响。方法 用高脂饲料喂养KK-A(y)转基因小鼠以诱导高血糖肥胖型DM模型。将同龄小鼠作为正常对照组(给予等体积无菌水,n = 11)。将55只成功建模的DM肥胖小鼠按随机数字表法分为5组(每组11只),包括模型组(给予等体积无菌水,未治疗)、盐酸吡格列酮片治疗组(8 mg/kg;作为阳性对照组)和JTXZT组[高剂量组(10.0 g生药/kg)、中剂量组(5.0 g生药/kg)和低剂量组(2.5 g生药/kg)]。所有药物均经灌胃给药,每天1次,连续8周。治疗8周后称取所有小鼠体重并测定随机血糖(RBG)水平。从眼静脉取血。检测胰岛素(INS)、血清总胆固醇(TC)和甘油三酯(TG)水平。计算HOMA-IR和ISI。取胰腺组织进行形态学改变的病理检查。采用免疫组织化学(IHC)法检测INS和胰岛素受体(InsR)的表达。用蛋白质印迹法检测胰腺组织中胰岛素受体β(InsRβ)和胰岛素受体底物-1(IRS-1)的表达。结果 与正常对照组相比,建模后各组均出现肥胖,血糖和血脂明显升高(P < 0.01)。给药8周后,模型组小鼠体重增加(P < 0.01),血糖和血脂维持在较高水平。与模型组相比,各JTXZT组小鼠体重、血清TG、INS水平及HOMA-IR明显降低(P < 0.05,P < 0.01)。此外,高剂量JTXZT组RBG明显降低(P < 0.01)。低剂量和高剂量JTXZT组ISI明显升高(P < 0.05,P < 0.01)。胰腺HE染色病理结果显示,模型组胰岛萎缩,数量明显减少,分布稀疏,胰岛密度降低。胰岛细胞代偿性肥大,有空泡变性。模型组还可见胰岛细胞凋亡,表现为细胞质肿胀和核固缩。高剂量和中剂量JTXZT组胰岛数量明显增加,凋亡和变性细胞减少。IHC检测结果显示,与正常对照组相比,模型组INS和InsR的灰度值明显降低(P < 0.01)。与模型组相比,各JTXZT组INS和InsR的免疫反应强度(IOD)值明显升高(P < 0.05,P < 0.01)。蛋白质印迹法结果显示,与正常对照组相比,模型组InsRβ和IRS-1的蛋白表达明显降低(P < 0.01)。与模型组相比,各JTXZT组InsRβ和IRS-1的蛋白表达明显升高(P < 0.01),但与盐酸吡格列酮片治疗组相比无统计学差异(P > 0.05)。结论 JTXZT对糖尿病肥胖型KK-A(y)转基因小鼠模型具有明显的降低血糖、血脂水平及改善胰岛素抵抗的作用。其机制可能与增加胰腺细胞中InsRβ和IRS-1的表达、促进INS与受体的结合,从而改善糖代谢、脂代谢及胰岛素抵抗状态有关。